StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Tuesday. The firm issued a hold rating on the stock.
China Pharma Stock Performance
NYSE CPHI opened at $0.26 on Tuesday. The company has a 50-day moving average price of $0.23 and a two-hundred day moving average price of $0.25. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.16. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84.
China Pharma (NYSE:CPHI – Get Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%. The company had revenue of $0.93 million during the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Read More
- Five stocks we like better than China Pharma
- Where to Find Earnings Call Transcripts
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Why Invest in High-Yield Dividend Stocks?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Upcoming IPO Stock Lockup Period, Explained
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
